Kristin Abate

Insider Reports History

Entity
Individual
Location
C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, Newton, MA
Signature
Nancy Smith, Attorney-in-Fact for Kristin Abate
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristin Abate:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. Chief Accounting Officer Common Stock 140K $128K $0.91 Nov 6, 2024 Direct

Insider Reports Filed by Kristin Abate

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. Nov 6, 2024 0 $0 3 Nov 22, 2024 Chief Accounting Officer